{"id":1615,"date":"2018-03-30T11:10:00","date_gmt":"2018-03-30T03:10:00","guid":{"rendered":"https:\/\/vcro.online\/?p=1615"},"modified":"2024-07-12T11:10:36","modified_gmt":"2024-07-12T03:10:36","slug":"congratulation-an-orphan-drug-designation-odd-of-autologous-immune-cell-therapy-for-treating-hepatocellular-carcinoma-was-granted-by-the-us-fda","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=1615","title":{"rendered":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA!"},"content":{"rendered":"\n<p>Recently, another new achievement was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO). A startup biotech company, which was assisted by VCRO, was granted ODD for an autologous immune cell product for preventing recurrence of HCC from the FDA. This ODD grant is a proof of the professional in the new drug development of VCRO. The professional, integrated, and local team of VCRO helps our customers to achieve the product in the niche of strategy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recently, another new achievement was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO). A startup biotech company, which was assisted by VCRO, was granted ODD for an autologous immune cell product for preventing recurrence of HCC from the FDA. This ODD grant is a proof of the professional in the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1615","post","type-post","status-publish","format-standard","hentry","category-vcro-express"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! - VCRO<\/title>\r\n<meta name=\"description\" content=\"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=1615\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=1615\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2018-03-30T03:10:00+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-12T03:10:36+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\" \/>\r\n\t<meta property=\"og:image:width\" content=\"512\" \/>\r\n\t<meta property=\"og:image:height\" content=\"512\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1615#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1615\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA!\",\"datePublished\":\"2018-03-30T03:10:00+00:00\",\"dateModified\":\"2024-07-12T03:10:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1615\"},\"wordCount\":101,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1615\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=1615\",\"name\":\"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"datePublished\":\"2018-03-30T03:10:00+00:00\",\"dateModified\":\"2024-07-12T03:10:36+00:00\",\"description\":\"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1615#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=1615\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1615#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! - VCRO","description":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=1615","og_locale":"en_US","og_type":"article","og_title":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! - VCRO","og_description":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=1615","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2018-03-30T03:10:00+00:00","article_modified_time":"2024-07-12T03:10:36+00:00","og_image":[{"width":512,"height":512,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","type":"image\/png"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=1615#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=1615"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA!","datePublished":"2018-03-30T03:10:00+00:00","dateModified":"2024-07-12T03:10:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1615"},"wordCount":101,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=1615","url":"https:\/\/www.vcro.com.tw\/?p=1615","name":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"datePublished":"2018-03-30T03:10:00+00:00","dateModified":"2024-07-12T03:10:36+00:00","description":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA! VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=1615#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=1615"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=1615#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA!"}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1615"}],"version-history":[{"count":1,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1615\/revisions"}],"predecessor-version":[{"id":1616,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1615\/revisions\/1616"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}